5 times next the primary outcome assessment day. As well as PTSD symptom enhancement, the ketamine group exhibited markedly larger reduction in comorbid depressive indications as opposed to midazolam group, which is notable given the high comorbidity of depression in people with PTSD. Study findings more advised that repeated ketamine https://caten355csh4.wikimeglio.com/user